MORGAN STANLEY PLC/CALL/CENTENE/65/0.1/20.12.24 Share Price

Warrant

DE000MB3YB79

Real-time Bid/Ask 07:45:41 27/06/2024 pm IST
0.72 EUR / 0.73 EUR -3.33% Intraday chart for MORGAN STANLEY PLC/CALL/CENTENE/65/0.1/20.12.24
Current month-25.74%
1 month-44.85%
Date Price Change
27/24/27 0.74 -1.33%
26/24/26 0.75 +2.74%
25/24/25 0.73 -2.67%
24/24/24 0.75 +4.17%
21/24/21 0.72 +1.41%

Delayed Quote Börse Stuttgart

Last update June 27, 2024 at 04:22 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying CENTENE CORPORATION
Issuer Morgan Stanley
WKN MB3YB7
ISINDE000MB3YB79
Date issued 24/02/2023
Strike 65 $
Maturity 20/12/2024 (176 Days)
Parity 10 : 1
Emission price 2.24
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 1.96
Lowest since issue 0.68
Delta0.65x
Omega 5.610
Premium8.42x
Gearing8.69x
Moneyness 1.032
Difference Strike -2.355 $
Difference Strike %-3.62%
Spread 0.02
Spread %2.74%
Theoretical value 0.7250
Implied Volatility 31.53 %
Total Loss Probability 43.84 %
Intrinsic value 0.1951
Present value 0.5299
Break even 72.77 €
Theta-0.01x
Vega0.02x
Rho0.02x

Company Profile

Centene Corporation specializes in health services. Revenues break down by activity as follows: - development of health insurance programs (91%): primarily for children, pregnant women, blind and disabled persons; - specialized services (9%): pharmaceutical services (claims processing, pharmacy network management, mail order sales, home delivery, analysis and clinical consulting services, etc.), health care services by education and empowerment (behavioral orientation programs and welfare, nursing advice, etc.), eye and dental care services, home care services, development of health care management solutions, etc.
Sector
-
More about the company

Ratings for Centene Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Centene Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
67.72 USD
Average target price
87.52 USD
Spread / Average Target
+29.23%
Consensus